Search results
New owner for Cosmos
Cosmos· 5 days agoAustralia’s premier popular science magazine has a new home. Cosmos, including the quarterly Cosmos Magazine, digital science news service, and the education ...
Petri Dish: Ipsen’s drug approval; Discovery expands local footprint - Boston Business Journal
The Business Journals· 6 days agoDrug approvals were at the center of two stories this week in the Petri Dish, as we dive into a...
Meet the 'Echidnapus,' an Extinct Creature That Resembles Both the Echidna and Platypus of Today
Smithsonian Magazine· 5 days agoToday, egg-laying mammals are rare oddballs, with creatures like the platypus and echidna standing...
MONECO Advisors LLC Has $512,000 Stake in Gilead Sciences, Inc. (NASDAQ:GILD)
ETF DAILY NEWS· 13 hours agoMONECO Advisors LLC raised its stake in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 12.3% in the fourth quarter, according to its most recent 13F filing with the SEC. The ...
Takeda’s epilepsy drug misses main goals in late-stage trials - Boston Business Journal
The Business Journals· 1 day agoTakeda Pharmaceuticals Inc. shared disappointing results from two late-stage trials for rare forms...
GROWING OLD UNGRACEFULLY: Is You Happy?
Lost Coast Outpost· 2 days agoThe United States now ranks below Slovenia (21) and United Arab Emirates (22); but above Germany (24) and Mexico (25). The 2024 World Happiness Report, issued last March 20 (United Nations International Day of Happiness).
Slagle Financial LLC Has $4.14 Million Stake in Gilead Sciences, Inc. (NASDAQ:GILD)
ETF DAILY NEWS· 2 days agoSlagle Financial LLC boosted its stake in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 99.0% during the 4th quarter, according to the company in its most recent filing with the Securities ...
Australian pterosaur had a huge tongue to help gulp down prey
New Scientist· 6 days agoA 100-million-year-old fossil pterosaur found in Australia may have had the largest and most...
Sarepta’s stock gains after Pfizer’s Duchenne trial failure - Boston Business Journal
The Business Journals· 5 days agoSarepta Therapeutics, a Cambridge drugmaker known for its Duchenne muscular dystrophy treatments,...
Gilead Sciences, Inc. (NASDAQ:GILD) Short Interest Up 17.2% in May
ETF DAILY NEWS· 19 hours agoGilead Sciences, Inc. (NASDAQ:GILD – Get Free Report) was the target of a significant increase in short interest during the month of May. As of May 31st, there was short interest totalling 25,430,000 ...
